Adjuvant therapy of ovarian cancer - Is there reason for optimism?

被引:0
|
作者
Alberts, DS
Garcia, DJ
机构
来源
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:207 / 216
页数:10
相关论文
共 50 条
  • [31] Editorial comment: Reason for optimism
    Diekema, DJ
    Pfaller, MA
    INFECTIONS IN MEDICINE, 2003, 20 (08) : 396 - 396
  • [32] Polyclonal antitumor immunoglobulin may play a role in ovarian cancer adjuvant therapy
    Tang, Lei
    Zhao, Xia
    MEDICAL HYPOTHESES, 2011, 76 (04) : 530 - 532
  • [34] Hyperthermia as an adjuvant therapy to chemotherapy for the treatment of advanced ovarian cancer complicated by ascites
    He, Lang
    Wang, Jun
    Chen, Hong
    Wu, Xun
    Tang, Lina
    Wang, Xiaoshan
    Lei, Jianguo
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (18): : 8115 - 8120
  • [35] Paclitaxel in advanced ovarian cancer: Too much optimism?
    Bulusu, VR
    Allerton, R
    GYNECOLOGIC ONCOLOGY, 1997, 66 (02) : 335 - 335
  • [36] ADJUVANT CANCER THERAPY
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1964, 189 (09): : 692 - &
  • [37] ADJUVANT THERAPY IN OVARIAN-CARCINOMA ASSESSED
    RAUB, W
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (21): : 2870 - 2870
  • [38] Aromatase inhibitor plus ovarian suppression as adjuvant therapy in premenopausal women with breast cancer
    Figg, William D., II
    Cook, Katherine
    Clarke, Robert
    CANCER BIOLOGY & THERAPY, 2014, 15 (12) : 1586 - 1587
  • [39] Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer
    Rowan T. Chlebowski
    Kathy Pan
    Nananda F. Col
    Breast Cancer Research and Treatment, 2017, 161 : 185 - 190
  • [40] Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer
    Muti, Paola
    Secreto, Giorgio
    Krogh, Vittorio
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 163 (03) : 631 - 632